32
15
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T4328 |
OSS_128167
SIRT6-IN-1 |
HBV; Sirtuin | Chromatin/Epigenetic; DNA Damage/DNA Repair; Microbiology/Virology |
OSS_128167 (SIRT6-IN-1) 是一种选择性沉默调节蛋白 6 (SIRT6) 抑制剂,对 SIRT6,SIRT1 和 SIRT2 的 IC50分别为 89 μM,1578 μM 和 751 μM。它具有抗 HBV、抗癌、抗炎和抗病毒活性,可抑制 HBV 的转录和复制。 | |||
T6439 |
Cetylpyridinium Chloride
西吡氯铵,Cetamium,Pristacin,Hexadecylpyridinium Chloride |
Others; HBV; Antibacterial | Microbiology/Virology; Others |
Cetylpyridinium Chloride (Hexadecylpyridinium Chloride) 是阳离子季铵,是一种广谱抗菌剂。它有效抑制 HBV 衣壳装配,IC50为 2.5 μM。它被用于杀虫剂和各种漱口水以及其他个人护理产品中。 | |||
T11669 |
IR415
|
HBV | Microbiology/Virology |
IR415 选择性地与 HBx 相互作用 (Kd=2 nM) 并阻断 HBV 介导的 RNAi 抑制,逆转 HBx 蛋白对 Dicer 核糖核酸内切酶活性的抑制作用。IR415 具有抗 HBV 的活性。 | |||
T11550 |
Helioxanthin derivative 5-4-2
Helioxanthin 5-4-2 |
HBV | Microbiology/Virology |
Helioxanthin derivative 5-4-2 (Helioxanthin 5-4-2) 是螺旋黄质的类似物,在体外显示出抗 HBV 活性,可用于研究HBV。 | |||
T16366 |
NVR 3-778
|
HBV | Microbiology/Virology |
NVR 3-778 是一种 SBA 类的口服有效HBV CAM 衣壳组装调制剂,具有抗 HBV 活性。 | |||
T8471 |
Vonafexor
EYP001,PLX007,pxl007 |
FXR; HBV | Metabolism; Microbiology/Virology |
Vonafexor (EYP001) 是一种法尼醇 X 受体激动剂,具有抗 HBV 作用。 | |||
T4121 |
Bicyclol
SY801,双环醇 |
HBV; Autophagy | Autophagy; Microbiology/Virology |
Bicyclol (SY801) 是一种抗肝炎 HBV 和 HCV 药物。 | |||
T76937 |
Burfiralimab
hzVSF-v13 |
HBV | Microbiology/Virology |
Burfiralimab (hzVSF-v13) 是一种针对波形蛋白的单克隆免疫球蛋白(IgG4),具有抗HBV作用,可用于研究类风湿关节炎。 | |||
T67797 |
DDG-39
1-(2,3-dideoxy-2-fluoropentofuranosyl)cytosine |
Antiviral; HBV; HIV Protease | Immunology/Inflammation; Microbiology/Virology; Proteases/Proteasome |
DDG-39 (1-(2,3-dideoxy-2-fluoropentofuranosyl)cytosine)具有抗病毒活性,在细胞培养中具有有效的选择性抗 HIV-1 和HBV 活性。平均抗病毒 IC50为0.61μM。 | |||
T39043 |
Tenofovir amibufenamide
HS-10234 |
HBV | Microbiology/Virology |
Tenofovir amibufenamide (HS-10234) (HS-10234) 是一种 Tenofovir 前药,是一种具有口服活性的抗病毒化合物。Tenofovir amibufenamide 对乙型肝炎病毒 (HBV)具有抑制作用,可用于慢性乙型肝炎 (CHB) 研究。 | |||
T26771 |
Bentysrepinine
Y 101,Y101,Y-101 |
||
Bentysrepinine, a novel anti-HBV agent, inhibits DNA-HBV and cccDNA activities for the treatment of hepatitis B virus (HBV)-infected hepatitis. | |||
T39744 |
Firzacorvir
|
||
Firzacorvir is a cyclic sulfamide compound that acts as an HBV core protein modulator and exhibits potent anti-HBV activity, with an EC50 value of < 1 μΜ. | |||
T61115 |
HBV-IN-25
|
||
HBV-IN-25 is a novel chemical compound that acts as a potent HBV cccDNA reducer when administered orally. It exhibits significant anti-HBeAg potency and anti-HBV activity, with IC50 values of 0.58 μM and 1.15 μM, respectively. Moreover, HBV-IN-25 demonstrates favorable aqueous solubility (LYSA>452 μg/mL) and no cellular toxicity, making it a promising candidate for further investigation and development [1]. | |||
T72796 |
Junceellolide C
|
||
Junceellolide C 是一种 cccDNA 转录抑制剂。Junceellolide C 能抑制 HepAD38 细胞中 HBVDNA 的复制,且能显著降低细胞上清液中的 HBVRNA 水平,其 EC50值分别为 5.19 和 3.52 μM。Junceellolide C 具有抗乙肝病毒活性。 | |||
T36747 |
HBV-IN-4
|
||
HBV-IN-4, a derivative of phthalazinone, functions as a potent, orally active inhibitor of HBV DNA replication, exhibiting an IC50 value of 14 nM. It effectively induces the formation of genome-free capsids, demonstrating significant anti-HBV potency[1]. | |||
T73147 |
Neracorvir
|
||
Neracorvir 是一种有效的抗病毒剂。Neracorvir 表现出抗 HBV 活性。 | |||
T29198 |
Z060228
Z 060228,Z-060228 |
||
Z060228 is an potent anti-HBV inhibitor. The HBV DNA replication was effectively inhibited by Z060228 in the supernatants of the HepG2.2.15 cells. Z060228 exhibited effects on the self-assembly of Cp149. SEC data revealed that Z060228 altered the equilibr | |||
T62704 | HBV-IN-23 | ||
HBV-IN-23 (Compound 5k) 是一种 HBV DNA 复制抑制剂 (IC50: 0.58 μM)。HBV-IN-23 能够抑制药物敏感和耐药株。HBV-IN-23 可以诱导 HepG2 细胞凋亡,表现出抗肝癌细胞 (HCC) 效果。 | |||
T62626 | HBV-IN-12 | ||
HBV-IN-12 是一种乙型肝炎表面抗原 (HBsAg) 的有效抑制剂,其 EC50 值大于 0.001 μM 且不大于 0.05 μM。HBV-IN-12 具有抗 HBV DNA 活性,其 EC50 值大于 0.001 μM 且不大于 0.02 μM。 | |||
T77001 | Exbivirumab | ||
Exbivirumab 是一种抗HBV 单克隆抗体。Exbivirumab 能增强乙型肝炎免疫球蛋白 (HBIG) 的抗病毒活性。 | |||
T78783 |
HBV-IN-35
|
HBV | Microbiology/Virology |
HBV-IN-35(Compound 88)是具有对小鼠和人肝细胞中HBV抗病毒活性的抑制剂,其EC50值分别为100 nM和400 nM。 | |||
T73282 |
HBV-IN-31
|
||
HBV-IN-31 是一种有效的共价闭合环状 DNA (cccDNA) 抑制剂。HBV-IN-31 具有抗HBV 活性,对 HBsAg 的 IC50值为 0.13 µM。HBV-IN-31 抑制细胞生长。 | |||
T11549 |
Helioxanthin 8-1
Helioxanthin analogue 8-1 |
Others | Others |
Helioxanthin 8-1, an analogue of helioxanthin, exhibits significant in vitro anti-HBV/HCV/HSV-1/HIV activity with EC50 of >5/10/1.4/15 μM. | |||
T73283 | HBV-IN-32 | ||
HBV-IN-31 是一种有效的共价闭合环状 DNA (cccDNA) 抑制剂。HBV-IN-31 具有抗HBV 活性,对 HBsAg 的 IC50值为 0.14 µM。HBV-IN-31 抑制细胞生长。 | |||
T72324 | Lagociclovir valactate | ||
Lagociclovir valactate 是 Lagociclovir 的前药。Lagociclovir valactate 是一种具有口服活性的抗HBV 试剂。 | |||
T60285 |
L-2'-Fd4C
|
||
L-2'-Fd4C 是一种L-核苷类似物,具有抗人类免疫缺陷病毒 (HIV) 和抗乙型肝炎病毒 (HBV) 活性。 | |||
T78756 | Yhhu6669 | HBV | Microbiology/Virology |
Yhhu6669为抗HBV药物,能够抑制HBVDNA。该化合物通过诱导无DNA衣壳的形成,从而抑制HBV复制,且能有效降低AAV/HBV感染小鼠中的HBVDNA及HBcAg水平,展现出优良的药代动力学特性。 | |||
T79469 | HBV-IN-34 | HBV | Microbiology/Virology |
HBV-IN-34(化合物17i)是一款抗HBV药物,可以有效抑制HBsAg的生成。在体外实验中,HBV-IN-34对HBVDNA和HBsAg的EC50值分别为0.018 μM和0.044 μM,显示出卓越的抗病毒活性。 | |||
T78812 |
HBV-IN-36
|
HBV | Microbiology/Virology |
HBV-IN-36(compound 42)是一种抗乙型肝炎病毒(HBV)活性显著的化合物,其抑制剂效力(IC50=2 μM)以及EC50值为0.85 μM,表明其作为HBV抑制剂具有潜在的临床应用价值。 | |||
T76321 |
Brain Derived Basic Fibroblast Growth Factor (1-24)
|
||
Brain Derived BasicFibroblast Growth Factor(1-24) (FGF basic 1-24) 是一种合成肽,表现出抗细菌和抗HBV 的活性。Brain Derived BasicFibroblast Growth Factor(1-24) 可用于感染性疾病和免疫性疾病的研究。 | |||
T60374 |
L-Fd4A
|
||
L-Fd4A (compound 36) 是腺嘌呤衍生物,具有抗人类免疫缺陷病毒 (HIV) (EC50=1.5 μM) 和抗乙型肝炎病毒 (HBV) (EC50=1.7 μM) 活性。L-Fd4A 具有低细胞毒性。 | |||
T37065 |
6-Chloro-2-fluoropurine
|
||
6-Chloro-2-fluoropurine is a heterocyclic building block.1,2It has been used in the synthesis of purine nucleosides that inhibit cyclin-dependent kinases (CDKs)in vitro.16-Chloro-2-fluoropurine has also been used in the synthesis of purine nucleosides that are active against HIV-1 and hepatitis B virus (HBV)in vitro.2 1.Wilson, S.C., Atrash, B., Barlow, C., et al.Design, synthesis and biological evaluation of 6-pyridylmethylaminopurines as CDK inhibitorsBioorg. Med. Chem.19(22)6949-6965(2011) 2.... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN1482 |
Chamaechromone
|
P450; HBV | Metabolism; Microbiology/Virology |
Chamaechromone 是从 Stellera chamaejasme L. 的根中分离出来的天然产物。 Chamaechromone 具有抗 HBV 和杀虫活性。 | |||
T4S1718 |
Punicalin
|
HBV; HIV Protease | Microbiology/Virology; Proteases/Proteasome |
Punicalin 是从Punica granatumL. 或Terminalia catappaL. 的叶子中分离的,一种可水解的单宁,具有抗炎活性。它是一种抗乙型肝炎病毒药物。 | |||
T2780 |
Catalpol
梓醇,Catalpinoside,Digitalis purpurea L |
Others; HBV | Microbiology/Virology; Others |
Catalpol (Catalpinoside) 是一种在Rehmannia glutinosa 中发现的鸢尾花苷,具有神经保护、降血糖、抗癌、抗痉挛、抗氧化、抗HBV 和抗肝炎病毒作用。 | |||
T3921 |
Punicalagin
安石榴甙,安石榴苷 |
SARS-CoV; HBV | Microbiology/Virology |
Punicalagin 是一种在石榴中发现的主要鞣花单宁,是可逆且非竞争性的3CLpro 抑制剂,有抗氧化、抗炎和抗癌作用。它有潜力研究 COVID-19 。 | |||
T2S1158 |
4,5-Dicaffeoylquinic acid
3,4-Dicaffeoylquinic acid,异绿原酸C(4,5),Isochlorogenic acid C |
Others; HBV; Endogenous Metabolite | Metabolism; Microbiology/Virology; Others |
4,5-Dicaffeoylquinic acid (Isochlorogenic acid C) 是一种天然产物,有抗病毒、抗肝毒性活性。 | |||
TN5845 |
Neochlorogenic acid methyl ester
5-O-Caffeoylquinic acid methyl ester,Methyl 3-caffeoylquinate,GIP (1-39) acetate(725474-97-5 Free base),Methyl neochlorogenate,新绿原酸甲酯 |
Antioxidant; HBV | Microbiology/Virology; oxidation-reduction |
Neochlorogenic acid methyl ester (5-O-Caffeoylquinic acid methyl ester) 来源于毛蒿和黑色苦莓(Aronia melanocarpa)果实。Neochlorogenic acid methyl ester 显示出抗 HBV 活性、抗氧化活性和醌还原酶活性,CD 为 6.7 μM。 | |||
T3794 |
Pentagalloylglucose
Penta-O-galloyl-β-D-glucose,1,2,3,4,6-O-Pentagalloylglucose,1,2,3,4,6-Penta-O-galloyl-beta-D-glucopyranose,1,2,3,4,6-五没食子酰葡萄糖 |
Influenza Virus | Microbiology/Virology |
1,2,3,4,6-O-Pentagalloylglucose (Penta-O-galloyl-β-D-glucose) 存在于多种植物中,具有重要的药理作用。Pentagalloylglucose 表现出显著的抗狂犬病病毒 (RABV) 活性。 | |||
T5S2254 |
Swertianolin
Bellidifolin-8-O-Glucoside,当药醇苷 |
Others; HBV; Antibacterial; AChE | Microbiology/Virology; Neuroscience; Others |
Swertianolin (Bellidifolin-8-O-Glucoside) 是从Gentianella Acuta 分离得到的一种黄酮,具有抗 HBV 和抗菌活性,可抑制乙酰胆碱酯酶。 | |||
TN2188 |
Schisanwilsonin B
Schisanwilsonin I,鹤庆五味子素 B |
Others | Others |
Schisanwilsonin D, and schisantherin C show anti-HBV activity. | |||
TN1732 | Herpetone | HBV | Microbiology/Virology |
Herpetone exhibits protective effects on CCl(4)-induced hepatocyte injury, it shows anti-hepatitis B virus (HBV) activity. | |||
T79975 |
Dihydrodehydrodiconiferyl alcohol 9-O-α-L-rhamnopyranoside
|
HBV | Microbiology/Virology |
Dihydrodehydrodiconiferyl alcohol 9-O-α-L-rhamnopyranoside(化合物1)是一种具有抗HBV活性的木脂素类化合物。该化合物对HBV表面抗原(HBsAg)的IC50为0.58 mM,而对HBV e抗原(HBeAg)的IC50 > 2.4 mM。其可从八角茴香中提取分离。 | |||
T79976 |
Dihydrodehydrodiconiferyl alcohol 9-O-β-D-xylopyranoside
|
HBV | Microbiology/Virology |
Dihydrodehydrodiconiferyl alcohol 9-O-β-D-xylopyranoside 作为一种抗HBV剂,在Hep G2.2.15细胞系上能够抑制HBsAg和HBeAg的分泌,其IC50值分别约为1.67 mM和>2.15 mM。 | |||
TN3687 |
Coclauril
|
HBV | Microbiology/Virology |
Coclauril shows anti-Hepatitis B virus (HBV) activities, with EC50 values of 7.6 ± 0.5 ug/mL. | |||
TN2220 |
Sophoranol
槐醇,(+)-Sophoranol |
HBV | Microbiology/Virology |
(+)-Sophoranol exhibits antiviral activity against the Coxsackie virus B3. It also shows potent anti-HBV activity with an inhibitory potency against HBsAg secretion and against HBeAg secretion. | |||
T81531 |
Pedunculosumoside F
|
||
Pedunculosumoside F,一种从Ophioglossum pedunculosum分离得到的同型黄酮苷,对HepG2 2.2.15细胞表现出细胞毒性,其CC50值为56.7 μM,但缺乏抗HBV活性。然而,其类似物能够抑制HBV感染的HepG2 2.2.15细胞中HBsAg的分泌。 |